Mast Therapeutics Inc : Mast Therapeutics Releases Positive Data In Model Of ... 4-traders (press release) Mast Therapeutics announced that, in a placebo-controlled, nonclinical model of chronic heart failure, MST-188 demonstrated a statistically significant improvement in numerous parameters of heart function, including left ventricular ejection fraction ... Mast Therapeutics Provides Enrollment Update On Phase 3 "EPIC" Study Of ... |
